ECOG-ACRIN EA8185

Phase 2 Study of Bladder-SparIng ChemoradiatioN with MEDI4736 (durvalumab) in Clinical Stage 3, node PosItive BladdeR CancEr (INSPIRE)

For more information about this clinical trial, click here

Schema & Eligibility ECOG-ACRIN EA8185

Available at:

CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Delbert Day Cancer Institute at PCRMC, Rolla, MO
Freeman Health System, Joplin, MO
Good Samaritan Regional Health Center, Mt. Vernon, IL
Mercy Hospital, St. Louis, MO
Mercy South, St. Louis, MO
Mercy Hospital, Oklahoma City, OK
Mercy Hospital, Fort Smith, AK
Mercy Hospital, Joplin, MO
Mercy Clinic Cancer & Hematology, Rolla, MO
Mosaic Life Care, St. Joseph, MO

Ask your physician about participating in this clinical trial or call us.